POPULARITY
32 episodes with reviva
55 episodes with reviva
8 episodes with reviva
10 episodes with reviva
20 episodes with reviva
6 episodes with reviva
39 episodes with reviva
2 episodes with reviva
2 episodes with reviva
2 episodes with reviva
2 episodes with reviva
2 episodes with reviva
2 episodes with reviva
11 episodes with reviva
2 episodes with reviva
9 episodes with reviva
7 episodes with reviva
6 episodes with reviva
5 episodes with reviva
5 episodes with reviva
4 episodes with reviva
4 episodes with reviva
4 episodes with reviva
3 episodes with reviva
3 episodes with reviva
3 episodes with reviva
2 episodes with reviva
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 04 de abril de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 03 de abril de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 02 de abril de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
O Autores e Livros Dose Extra desta semana conversa com Valter Lázaro, do perfil de quadrinhos no Instagram @novasvelhashqs sobre quadrinhos e dicas de leitura para adultos. Todas as dicas que o Valter deu no programa de hoje estão no Instagram. Basta usar #dicasautoreselivros. Lázaro sugere como leitura as seguintes Graphic Novels: • Nova York: a Vida na Grande Cidade, de Will Eisner. Nas quatro graphic novels reunidas neste livro, escritas nos anos 80 e 90, Will Eisner traça um retrato genuíno, ao mesmo tempo brutal e profundamente humano, da vida na cidade grande. Protagonizadas por personagens singulares, essas pequenas histórias registram momentos, às vezes irônicos, às vezes trágicos, da vida dos habitantes da metrópole, revelando muito mais do que “um acúmulo de grandes edifícios, grandes populações e grandes áreas”. • O inferno de Dante em Graphic Novel, de Paul e Gaëtan Brizzi. Nesta extraordinária adaptação em HQ da primeira parte de A Divina Comédia, um clássico que moldou a literatura mundial e o imaginário popular, o leitor acompanhará Dante Alighieri, guiado pelo poeta Virgílio, em sua jornada pelos nove círculos do Inferno na intensa busca por sua amada Beatriz no Paraíso. Testemunhe a coragem e o desespero entrelaçados enquanto Dante enfrenta as profundezas obscuras e desconhecidas. • Monstros, por Barry Windsor-Smith Barry Windsor-Smith é uma lenda do quadrinho contemporâneo. Seu trabalho em personagens como Wolverine, X-Men, Demolidor e Conan é até hoje objeto de culto entre fãs de HQ. Monstros é sua obra mais ambiciosa. Elaborada ao longo de 35 anos, conta a história de um experimento genético nazista importado para os Estados Unidos. Como diz Neil Gaiman, Monstros está naquele lugar raro onde "a arte e a imaginação se encontram". • Chew - O Sabor do Crime, de John Layman e Rob Guillory Num mundo onde uma pandemia de gripe aviária matou mais de 23 milhões de pessoas e o consumo de carne de frango é proibido, nós iremos conhecer Tony Chu, um detetive com um segredo. Um segredo bem... esquisito. Chu é um Cibopata! Isso significa que ele faz parte de um pequeno grupo de pessoas capazes de receber impressões psíquicas de tudo aquilo que comem. Além disso Chu é um ótimo detetive, especialmente quando ele não se importa em mordiscar o corpo de uma vítima de assassinato para descobrir quem cometeu o crime e o motivo. Por causa de seus atributos, ele foi chamado para trabalhar nos casos mais bizarros e estranhos da Divisão de Crimes Especiais da F.D.A., agora a agência da lei mais poderosa do mundo! • Patrulha Estelar Yamato (Edição Histórica), por Leiji Matsumoto O ano é 2199, a Terra está sofrendo com as invasões e ataques do Império Gamilas, que força a humanidade a se refugiar em uma metrópole subterrânea, devido às armas de radiação. Mas a situação está rapidamente se deteriorando e, em dentro de um ano, o planeta inteiro se tornará inabitável. Em meio a isso, uma mensagem misteriosa vinda dos confins do universo é captada pela base de Marte, contendo o método para a produção do “motor de ondas” e instruções que usassem essa tecnologia de viagem espacial para ir até o planeta Iskandar, onde conseguiriam um dispositivo que eliminaria por completo toda a radiação dos gamilanos. Para essa missão é escolhido um antigo couraçado utilizado na guerra de 250 anos atrás, o Yamato. E assim, o Couraçado Espacial Yamato parte em rumo a uma galáxia distante para trazer à Terra, dentro de um ano, a única e última esperança da humanidade! Reviva as emoções do maior clássico de ópera espacial criado no Japão, exibido nas TVs brasileiras na década de 1980, agora em um mangá de volume único na edição Prime.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 28 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 27 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
In this CME podcast, Dr. Andrew Cutler and Dr. Roger McIntyre discuss the use of potentially unsafe drug combinations in patients with treatment-resistant psychiatric conditions. They review situations where complex medication regimens may be necessary and how clinicians may proceed in these instances. By addressing these topics, the podcast offers guidance on balancing the potential benefits of combination therapies with the risks associated with polypharmacy in psychiatric care. Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Identify common potentially unsafe drug combinations that may be considered in treatment-resistant cases Evaluate the risks and benefits of prescribing potentially unsafe drug combinations for treatment-resistant patients, considering factors such as efficacy, adverse effects, and patient-specific characteristics Develop strategies to monitor and manage patients prescribed potentially unsafe drug combinations Accreditation: In support of improving patient care, this activity has been planned and implemented by HMP Education and Neuroscience Education Institute (NEI). HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with synchronized audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit. Estimated Time to Complete: 1 hour. Released: March 26, 2025* Expiration: March 25, 2028 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD25-01 Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ HMP Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse: ANCC contact hours This continuing nursing education activity awards 1.00 contact hour. Provider approved by the California Board of Registered Nursing, Provider #18006 for 1.00 contact hour. Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.00 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.00 contact hour (.10 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI and HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and are unable to report your claimed credit after this 60-day period. Ensure your profile includes your DOB and NABP ID. Physician Associate/Assistant: AAPA Category 1 CME credits HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.00 AAPA Category 1 credit. Approval is valid until March 25, 2028. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. This activity awards 1.00 CE Credit. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, HMP Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1.00 general continuing education credit. Non-Physician Member of the Healthcare Team: Certificate of Participation HMP Education awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD, MPH specializing in forensics, psychosis, schizophrenia, mood disorders, anxiety, and cognitive disorders — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI and HMP Education take responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Any relevant financial relationships were mitigated prior to the activity being planned, developed, or presented. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, New York Chief Medical Officer, Neuroscience Education Institute, Malvern, Pennsylvania Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Roger S. McIntyre, MD, FRCPC Professor, Departments of Psychiatry and of Pharmacology, University of Toronto, Toronto, Ontario, Canada CEO, Braxia Scientific Corp, Toronto, ON, Canada Grant/Research: Canadian Institutes of Health Research, China National Natural Research Foundation, Global Alliance for Chronic Diseases, Milken Institute Consultant/Advisor: Alkermes, Atai Life Sciences, Axsome, Bausch Health, Biogen, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neumora Therapeutics, Neurocrine, NewBridge Pharmaceuticals, Novo Nordisk, Otsuka, Pfizer, Purdue, Sage, Sanofi, Sunovion, Takeda, Viatris The remaining Planning Committee members, Content Editors, Peer Reviewer, NEI and HMP planners/staff have no financial relationships to disclose. NEI and HMP Education planners and staff include Gabriela Alarcón, PhD, Ali Holladay, Andrea Zimmerman, EdD, CHCP, Brielle Calleo, and Steven S. Simring, MD, MPH. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported solely by the provider, NEI.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 26 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 26 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 25 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 21 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 21 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 20 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 17 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 17 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 13 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 13 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 12 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 12 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 10 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 11 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 10 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 10 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 07 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 05 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 04 de marzo de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 28 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 27 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 26 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 25 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 24 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 20 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 19 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 18 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 17 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 14 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 13 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 12 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 11 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 10 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 7 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 5 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 4 de febrero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 3 de enero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 31 de enero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 30 de enero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 29 de enero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
¡Ahora la radio no solo se escucha, también se ve! Reviva el programa completo del 28 de enero de 2025 en Mañanas Blu con Néstor Morales.See omnystudio.com/listener for privacy information.
During this A Public Affair, Madison Book Beat crossover episode, host Andrew Thomas and producer Jade Iseri-Ramos bring you a 2-hour jazz on vinyl special. The post Jazz on Vinyl: Improvised Music, Birth of the LP, and the Vinyl Reviva... appeared first on WORT-FM 89.9.
In this CME podcast, Dr. Andrew Cutler interviews Dr. Jonathan Meyer about the history of muscarinic receptor science in schizophrenia and how that informs the mechanisms of action of novel muscarinic-targeting drugs for this disorder. They also discuss the efficacy and safety of these drugs and provide practical strategies for prescribing xanomeline-trospium. Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Discuss the history of muscarinic receptor science and the role of muscarinic receptors in schizophrenia treatment Differentiate novel and in-development muscarinic-targeting treatments for schizophrenia based on their unique mechanisms of action, efficacy, and tolerability data Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit. Estimated Time to Complete: 1 hour Released: November 27, 2024* Expiration: November 26, 2027 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD24-SCHIZ01 Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Nurse: ANCC contact hours NEI designates this Enduring Material for a maximum of 1.0 ANCC contact hour Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.0 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.0 contact hour (.10 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and is unable to report your claimed credit after this 60-day period. Physician Associate/Assistant: AAPA Category 1 CME credits NEI has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.0 AAPA Category 1 credit. Approval is valid until November 26, 2027. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, NEI is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1 general continuing education credits. Non-Physician Member of the Healthcare Team: Certificate of Participation NEI awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD specializing in psychiatry and psychopharmacology — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Malvern, PA Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Jonathan M. Meyer, MD Voluntary Clinical Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA Consultant/Advisor: AbbVie, Alkermes, Bristol Myers Squibb, Intra-Cellular, Neurocrine, Sumitomo, Teva Speakers Bureau: AbbVie, Alkermes, Axsome, Bristol Myers Squibb, Intra-Cellular, Neurocrine, Teva The remaining Planning Committee members, Content Editors, Peer Reviewer, and NEI planners/staff have no financial relationships to disclose. NEI planners and staff include Caroline O'Brien, Gabriela Alarcón, PhD, Meghan M. Grady, BA, Andrea Zimmerman, EdD, CHCP, and Brielle Calleo. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement Contact Us: For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported by an educational grant from Bristol Myers Squibb.
© 2020-2025 Ivy Podcast Discovery LLC
